Tag: Novartis

There's a battle—or, at the very least, a whole lot of investor speculation—brewing in the heart drug space. (Granted, rampant ...

Celgene got good marks for a phase three trial for its MS drug. (Kris Tripplaar/Sipa USA/Newscom) ALLISON GATLIN 2/17/2017 Reprints ...

Novartis, also grappling with a slump at its eye-care division Alcon, is banking on newer treatments like heart medicine Entresto ...